• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRKN 突变的人类大脑和中脑类器官中星形胶质细胞反应性降低。

Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations.

作者信息

Kano Masayoshi, Takanashi Masashi, Oyama Genko, Yoritaka Asako, Hatano Taku, Shiba-Fukushima Kahori, Nagai Makiko, Nishiyama Kazutoshi, Hasegawa Kazuko, Inoshita Tsuyoshi, Ishikawa Kei-Ichi, Akamatsu Wado, Imai Yuzuru, Bolognin Silvia, Schwamborn Jens Christian, Hattori Nobutaka

机构信息

Department of Neurology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo, Tokyo, 113-8421, Japan.

Department of Neurology, Juntendo Koshigaya Hospital, 560 Fukuroyama, Koshigaya, Saitama, 343-0032, Japan.

出版信息

NPJ Parkinsons Dis. 2020 Nov 13;6(1):33. doi: 10.1038/s41531-020-00137-8.

DOI:10.1038/s41531-020-00137-8
PMID:33298969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7666226/
Abstract

Parkin (encoded by PRKN) is a ubiquitin ligase that plays an important role in cellular mitochondrial quality control. Mutations in PRKN cause selective dopaminergic cell loss in the substantia nigra and are presumed to induce a decrease in mitochondrial function caused by the defective clearance of mitochondria. Several studies have demonstrated that parkin dysfunction causes mitochondrial injury and astrocytic dysfunction. Using immunohistochemical methods, we analyzed astrocytic changes in human brains from individuals with PRKN mutations. Few glial fibrillary acidic protein- and vimentin-positive astrocytes were observed in the substantia nigra in PRKN-mutated subjects compared with subjects with idiopathic Parkinson's disease. We also differentiated patient-specific induced pluripotent stem cells into midbrain organoids and confirmed decreased numbers of glial fibrillary acidic protein-positive astrocytes in PRKN-mutated organoids compared with age- and sex-matched controls. Our study reveals PRKN-mutation-induced astrocytic alteration and suggests the possibility of an astrocyte-related non-autonomous cell death mechanism for dopaminergic neurons in brains of PRKN-mutated patients.

摘要

帕金蛋白(由PRKN基因编码)是一种泛素连接酶,在细胞线粒体质量控制中发挥重要作用。PRKN基因突变会导致黑质中多巴胺能细胞选择性缺失,据推测会因线粒体清除缺陷而导致线粒体功能下降。多项研究表明,帕金蛋白功能障碍会导致线粒体损伤和星形胶质细胞功能障碍。我们采用免疫组织化学方法,分析了携带PRKN基因突变个体的人脑星形胶质细胞变化。与特发性帕金森病患者相比,PRKN基因突变患者黑质中很少观察到胶质纤维酸性蛋白和波形蛋白阳性的星形胶质细胞。我们还将患者特异性诱导多能干细胞分化为中脑类器官,并证实与年龄和性别匹配的对照组相比,PRKN基因突变类器官中胶质纤维酸性蛋白阳性星形胶质细胞数量减少。我们的研究揭示了PRKN基因突变诱导的星形胶质细胞改变,并提示PRKN基因突变患者大脑中多巴胺能神经元可能存在与星形胶质细胞相关的非自主性细胞死亡机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/202e843ca4a0/41531_2020_137_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/a5dc731e1355/41531_2020_137_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/fc07e0b47ab3/41531_2020_137_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/deee621af194/41531_2020_137_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/f6151d15a0a7/41531_2020_137_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/202e843ca4a0/41531_2020_137_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/a5dc731e1355/41531_2020_137_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/fc07e0b47ab3/41531_2020_137_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/deee621af194/41531_2020_137_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/f6151d15a0a7/41531_2020_137_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4e/7666226/202e843ca4a0/41531_2020_137_Fig5_HTML.jpg

相似文献

1
Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations.PRKN 突变的人类大脑和中脑类器官中星形胶质细胞反应性降低。
NPJ Parkinsons Dis. 2020 Nov 13;6(1):33. doi: 10.1038/s41531-020-00137-8.
2
Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons.建立一种体外模型,用于分析 PRKN 突变患者 iPSC 衍生的多巴胺能神经元中的线粒体超微结构。
Mol Brain. 2021 Mar 23;14(1):58. doi: 10.1186/s13041-021-00771-0.
3
Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts.Parkin 突变降低了源自人成纤维细胞的神经元的神经突复杂性和成熟度。
Brain Res Bull. 2020 Jun;159:9-15. doi: 10.1016/j.brainresbull.2020.03.006. Epub 2020 Mar 7.
4
Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.帕金森病伴帕金基因突变患者皮肤成纤维细胞中的线粒体和自噬改变。
Aging (Albany NY). 2019 Jun 9;11(11):3750-3767. doi: 10.18632/aging.102014.
5
Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.帕金森病伴 parkin 基因突变患者皮肤成纤维细胞中的转录异常。
Neurobiol Aging. 2018 May;65:206-216. doi: 10.1016/j.neurobiolaging.2018.01.021. Epub 2018 Feb 7.
6
miR-218 Inhibits Mitochondrial Clearance by Targeting PRKN E3 Ubiquitin Ligase.miR-218 通过靶向 PRKN E3 泛素连接酶抑制线粒体清除。
Int J Mol Sci. 2020 Jan 5;21(1):355. doi: 10.3390/ijms21010355.
7
Dopaminergic Dysfunction and Glucose Metabolism Characteristics in Parkin-Induced Early-Onset Parkinson's Disease Compared to Genetically Undetermined Early-Onset Parkinson's Disease.与基因未确定的早发性帕金森病相比,帕金诱导的早发性帕金森病中的多巴胺能功能障碍和葡萄糖代谢特征
Phenomics. 2022 Oct 22;3(1):22-33. doi: 10.1007/s43657-022-00077-8. eCollection 2023 Feb.
8
PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis.PRKN 调控的细胞自噬和细胞衰老在 COPD 发病机制中的作用。
Autophagy. 2019 Mar;15(3):510-526. doi: 10.1080/15548627.2018.1532259. Epub 2018 Oct 13.
9
Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.星形胶质细胞功能障碍持续时间延长和小胶质细胞激活加速了大鼠黑质多巴胺能神经元的变性,并阻断了 6-OHDA 诱导的早期运动功能障碍的代偿。
Mol Neurobiol. 2018 Apr;55(4):3049-3066. doi: 10.1007/s12035-017-0529-z. Epub 2017 May 2.
10
Reduced ER-mitochondrial contact sites and mitochondrial Ca flux in -mutant patient tyrosine hydroxylase reporter iPSC lines.突变患者酪氨酸羟化酶报告诱导多能干细胞系中内质网-线粒体接触位点减少及线粒体钙通量降低。
Front Cell Dev Biol. 2023 Sep 8;11:1171440. doi: 10.3389/fcell.2023.1171440. eCollection 2023.

引用本文的文献

1
Human brain organoids: an innovative model for neurological disorder research and therapy.人类脑类器官:神经疾病研究与治疗的创新模型。
Front Cell Neurosci. 2025 Aug 26;19:1658074. doi: 10.3389/fncel.2025.1658074. eCollection 2025.
2
Genetic and epigenetic analysis of plasma glial fibrillary acidic protein (GFAP) levels in PTSD.创伤后应激障碍患者血浆中胶质纤维酸性蛋白(GFAP)水平的遗传和表观遗传分析
Mol Psychiatry. 2025 Sep 10. doi: 10.1038/s41380-025-03232-5.
3
Exploring Risk and Protective Factors in Parkinson's Disease.探索帕金森病的风险因素和保护因素。

本文引用的文献

1
3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing.用于高内涵表型分析和药物测试的帕金森病特异性多巴胺能神经元的3D培养
Adv Sci (Weinh). 2018 Nov 20;6(1):1800927. doi: 10.1002/advs.201800927. eCollection 2019 Jan 9.
2
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.患者特异性 iPSC 衍生星形胶质细胞在帕金森病中非细胞自主神经退行性变中发挥作用。
Stem Cell Reports. 2019 Feb 12;12(2):213-229. doi: 10.1016/j.stemcr.2018.12.011. Epub 2019 Jan 10.
3
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.
Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710.
4
The potential of brain organoids in addressing the heterogeneity of synucleinopathies.脑类器官在解决突触核蛋白病异质性方面的潜力。
Cell Mol Life Sci. 2025 Apr 28;82(1):188. doi: 10.1007/s00018-025-05686-w.
5
MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson's disease-associated dopaminergic neuron loss.MIRO1突变导致代谢适应不良,进而导致帕金森病相关的多巴胺能神经元丧失。
NPJ Syst Biol Appl. 2025 Apr 17;11(1):37. doi: 10.1038/s41540-025-00509-x.
6
Two- and Three-Dimensional In Vitro Models of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Applications.帕金森病和阿尔茨海默病的二维和三维体外模型:现状与应用
Int J Mol Sci. 2025 Jan 13;26(2):620. doi: 10.3390/ijms26020620.
7
Mitochondrial dysfunction in Parkinson's disease.帕金森病中的线粒体功能障碍。
J Neural Transm (Vienna). 2024 Dec;131(12):1415-1428. doi: 10.1007/s00702-024-02863-2. Epub 2024 Nov 25.
8
Ubiquitin system mutations in neurological diseases.泛素系统突变与神经疾病。
Trends Biochem Sci. 2024 Oct;49(10):875-887. doi: 10.1016/j.tibs.2024.06.011. Epub 2024 Jul 6.
9
Midbrain organoids-development and applications in Parkinson's disease.中脑类器官——在帕金森病中的发育与应用
Oxf Open Neurosci. 2023 Aug 18;2:kvad009. doi: 10.1093/oons/kvad009. eCollection 2023.
10
Pathogenesis of Parkinson's disease: from hints from monogenic familial PD to biomarkers.帕金森病的发病机制:从单基因家族性帕金森病的线索到生物标志物。
J Neural Transm (Vienna). 2024 Jun;131(6):709-719. doi: 10.1007/s00702-024-02747-5. Epub 2024 Mar 13.
遗传突触核蛋白病帕金森综合征的神经病理学:文献复习。
Mov Disord. 2017 Nov;32(11):1504-1523. doi: 10.1002/mds.27193.
4
Reactive Astrocytes: Production, Function, and Therapeutic Potential.反应性星形胶质细胞:产生、功能和治疗潜力。
Immunity. 2017 Jun 20;46(6):957-967. doi: 10.1016/j.immuni.2017.06.006.
5
An updated review of Parkinson's disease genetics and clinicopathological correlations.帕金森病遗传学与临床病理相关性的最新综述。
Acta Neurol Scand. 2017 Mar;135(3):273-284. doi: 10.1111/ane.12616. Epub 2016 Jun 8.
6
A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.一个携带新型PARK2突变的秘鲁家庭:临床和病理特征
Parkinsonism Relat Disord. 2015 May;21(5):444-8. doi: 10.1016/j.parkreldis.2015.01.005. Epub 2015 Jan 15.
7
Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system.中枢神经系统疾病中的胶质纤维酸性蛋白(GFAP)与星形胶质细胞中间丝系统
Curr Opin Cell Biol. 2015 Feb;32:121-30. doi: 10.1016/j.ceb.2015.02.004. Epub 2015 Mar 2.
8
Intermediate filaments are important for astrocyte response to oxidative stress induced by oxygen-glucose deprivation and reperfusion.中间丝对于星形胶质细胞对氧葡萄糖剥夺再灌注诱导的氧化应激的反应很重要。
Histochem Cell Biol. 2013 Jul;140(1):81-91. doi: 10.1007/s00418-013-1110-0. Epub 2013 Jun 12.
9
Parkin disease: a clinicopathologic entity?帕金森病:一种临床病理实体?
JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.
10
Lewy body pathology in a patient with a homozygous parkin deletion.路易体病理改变见于一名纯合子 parkin 缺失患者。
Mov Disord. 2013 Mar;28(3):388-91. doi: 10.1002/mds.25346. Epub 2013 Feb 11.